A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
Ohio joins Midwest XOR’s roster
Ohio University has signed up to a Kentucky-led online portal aimed at sourcing C-level executives for university-linked businesses.
VTT winds down Spinnova stake
VTT Ventures has exited textile fibre developer Spinnova, spun out from the research centre in 2014.
Serum braces for Vakzine acquisition
The vaccine developer had been backed by Helmholtz’s tech transfer partner Ascenion, its sponsor association Friends of the HZI and pharmaceutical consultancy Corvay.
Principia Biopharma primes $86m IPO
Principia Biopharma, whose drug discovery platform is based on research at UCSF, has filed for an $86.3m initial public offering having raised $50m earlier this month.
